Home/Filings/SCHEDULE 13D/A/0001140361-25-019024
SCHEDULE 13D/A//SEC Filing

BridgeBio Pharma, Inc. SCHEDULE 13D/A

Accession 0001140361-25-019024

CIK 0001780408other

Filed

May 13, 8:00 PM ET

Accepted

May 14, 5:52 PM ET

Size

24.9 KB

Accession

0001140361-25-019024

Issuer

KKR Genetic Disorder L.P.

CIK 0001780408

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001780408

Filing Metadata

Form type
SCHEDULE 13D/A
Filed
May 13, 8:00 PM ET
Accepted
May 14, 5:52 PM ET
Size
24.9 KB